Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema

Acta Ophthalmologica

Volumn 86, Issue 1, 2008, Pages 105-110

  Margolis, Ron ^a   Singh, Rishi P ^a   Bhatnagar, Pawan ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Clinically significant macular oedema; Diabetic retinopathy; Panretinal photocoagulation; Proliferative retinopathy; Triamcinolone acetonide

Indexed keywords

ANTIHYPERTENSIVE AGENT; ORAL ANTIDIABETIC AGENT; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; LASER COAGULATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA FOVEA; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; ADJUVANT CHEMOTHERAPY; INJECTION; MIDDLE AGED; PATHOPHYSIOLOGY; RETINA; RETINA MACULA EDEMA; VITREOUS BODY;

ADULT; CHEMOTHERAPY, ADJUVANT; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 39349091694     PISSN: 1755375X     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00940.x     Document Type: Article

References (24)

1. Bandello F, Polito A, Pognuz DR, Monaco P, Dimastrogiovanni A & Paissios J (2006): Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol 124: 643-650.
2. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB III & Miller M (2003): Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110: 681-686.
3. Brooks HL Jr, Caballero S Jr, Newell CK et.al. (2004): Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122: 1801-1807.
4. Cekic O, Chang S, Tseng JJ, Akar Y, Barile GR & Schiff WM (2005): Cataract progression after intravitreal triamcinolone injection. Am J Ophthalmol 139: 993-998.
5. Diabetic Retinopathy Study Research Group (1981): Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS). DRS Report 8. Ophthalmology 88: 583-600.
6. Early Treatment Diabetic Retinopathy Study Research Group (1985): ETDRS report, 1: Photocoagulation for diabetic macular edema. Arch Ophthalmol 103: 1796-1806.
7. Ferris FL III, Podgor MJ & Davis MD (1987): Macular edema in Diabetic Retinopathy Study (DRS): DRS Report number 12. Ophthalmology 94: 754-760.
8. Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E & Hori S (2003): Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol 135: 321-327.
9. Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W & Simpson JM (2005): Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 112: 139-143.
10. Jonas JB, Degenring RF, Kreissig I, Akkoyun I & Kamppeter BA (2005): Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112: 593-598.
11. Jonas JB & Sofker A (2001): Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132: 425-427.
12. KytöJP, Angerman S, Lumiste E, Paloheimo M & Summanen PA (2005): Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: Case report with 22 weeks follow-up. Acta Ophthalmol Scand 83: 605-608.
13. Larsson J, Zhu M, Sutter F & Gillies MC (2005): Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 139: 802-806.
14. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E & Baumal C (2002): Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109: 920-927.
15. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C & Gaudric A (2004): Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology 111: 218-225.
16. McDonald HR & Schatz H (1985a): Macular edema following panretinal photocoagulation. Retina 5: 5-10.
17. McDonald HR & Schatz H (1985b): Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 92: 388-393.
18. Moshfeghi DM, Kaiser PK, Scott IU et al. (2003): Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136: 791-796.
19. Nonaka A, Kiryu J, Tsujikawa A et al. (2002): Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci 43: 1204-1209.
20. Shimura M, Yasuda K, Nakazawa T, Kano T, Ohta S & Tamai M (2003): Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 110: 2386-2394.
21. Shimura M, Yasuda K, Nakazawa T & Tamai M (2005): Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Am J Ophthalmol 140: 8-15.
22. Shimura M, Yasuda K & Shiono T (2006): Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Ophthalmology 113: 381-387.
23. Thompson JT (2006): Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol 141: 629-637.
24. Zein WM, Noureddin BN, Jurdi FA, Schakal A & Bashshur ZF (2006): Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Retina 26: 137-142.